Medication info
Il-Yang Telmisartan Tablet 40 mg (Telmisartan)

Il-Yang Telmisartan Tablet 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Il-Yang Pharmaceutical Co., Ltd.
Appearance
White or off-white oval-shaped tablet
Packaging
30 tablets/box [10 tablets/Alu-Alu X 3]
Approval status
Active

MFDS item code 201003154 · Notified 2010.04.29 · Insurance code 641704100

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce cardiovascular risk, it is recommended that blood pressure be monitored, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Il-Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

This medication is used to treat essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death from cardiovascular disease in patients aged 55 years and older who are at high risk of cardiovascular disease, such as those with a history of coronary artery disease, peripheral artery disease, or stroke or evidence of end-organ damage in high-risk diabetic patients. Therefore, this drug is effective in controlling blood pressure while preventing the occurrence and progression of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this drug to reduce cardiovascular risk, it is recommended that blood pressure be monitored, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious damage to the fetus, especially during pregnancy, and must be discontinued immediately if pregnancy is confirmed. It should not be used by individuals allergic to this drug or its components, pregnant or breastfeeding women, patients with severe liver impairment, patients with a history of hereditary angioedema, and patients with diabetes or severe kidney impairment. Caution should be exercised when administering to elderly patients, patients with hyperkalemia, liver impairment, valvular heart disease, and ischemic heart disease, as severely low blood pressure may present serious problems. During treatment, various adverse reactions such as infections, blood abnormalities, hyperkalemia, hypoglycemia, depression, dizziness, hypotension, dyspnea, liver dysfunction, skin rash, myalgia, and renal dysfunction may occur, so symptoms should be closely monitored. If there are symptoms of angioedema (swelling of the face, lips, throat, tongue), immediately discontinue use and inform medical personnel. Patients with impaired renal function or undergoing dialysis should regularly check serum potassium and creatinine levels, as there is a risk of hypotension in cases of insufficient blood volume or sodium. This medication may enhance the hypotensive effects of other antihypertensive agents, and there may be increased risks of renal function deterioration, hyperkalemia, and hypotension when used in combination with certain drugs, so it should be taken after consulting with a doctor. Avoid taking this medication for 24 hours before surgery, and patients with gastrointestinal disorders should exercise caution due to the risk of gastrointestinal bleeding. Caution is needed when driving or operating machinery due to the possibility of dizziness or fainting. Taking an overdose may result in hypotension, arrhythmias, dizziness, acute kidney failure, etc., and immediate medical attention is required, as this drug is not removed by dialysis, necessitating careful observation and appropriate treatment. The safety and efficacy of this medication have not been established for children and adolescents under 18 years of age, so it is not recommended. This medication contains sorbitol, so patients with fructose intolerance should not take it, and patients at high risk of hyperkalemia, such as diabetics or those with kidney impairment, should carefully monitor potassium levels.

Side effects

  • Upper respiratory infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 99 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • fainting
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • indigestion
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • lumbago
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute kidney failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • lethargy
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • elevated serum myoglobin
  • increased urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • lack of effect
  • headache
  • dizziness
  • cough
  • indigestion
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • arrhythmia
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to safely preserve the drug's efficacy.

Appearance and packaging

Appearance

White or off-white oval-shaped tablet

Package unit

30 tablets/box [10 tablets/Alu-Alu X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.